VC Funding For Pharma Declines After Patent Rule Changes
Uncertainties in the U.S. patent system are causing venture capital funding to move away from pharmaceuticals, biotechnology and other sectors that are crucial to the country's national security and public safety,...To view the full article, register now.
Already a subscriber? Click here to view full article